These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9040425)

  • 1. Prevention of diabetic nephropathy.
    Materson BJ; Preston RA
    Hosp Pract (1995); 1997 Feb; 32(2):129-34, 139-40. PubMed ID: 9040425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE inhibitors as a shield against diabetic nephropathy.
    Materson BJ
    Arch Intern Med; 1996 Feb; 156(3):239-40. PubMed ID: 8572832
    [No Abstract]   [Full Text] [Related]  

  • 3. Practical problems in the management of hypertension in the diabetic patient.
    O'Hare JP
    J Diabetes Complications; 1996; 10(3):146-8. PubMed ID: 8807462
    [No Abstract]   [Full Text] [Related]  

  • 4. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
    Luño J; Valderrábano F
    An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of angiotensin-converting-enzyme inhibition in patients with renal disease.
    Manley HJ
    Am J Health Syst Pharm; 2000 Oct; 57 Suppl 1():S12-8. PubMed ID: 11030018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE inhibitors and renoprotection.
    Peterson K
    J Fam Pract; 1996 May; 42(5):453. PubMed ID: 8642355
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolving therapeutic strategies for retarding progression of diabetic nephropathy--an update for 2002.
    Epstein M
    Acta Diabetol; 2002 Jun; 39 Suppl 2():S41-5. PubMed ID: 12222627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study.
    Barnett AH
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S42-9. PubMed ID: 15868119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preserving the diabetic kidney.
    Poirier SJ
    J Fam Pract; 1998 Jan; 46(1):21-7. PubMed ID: 9451365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED; Preddie DC
    Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relations between arterial hypertension and diabetic nephropathy].
    Passa P; Marre M; Leblanc H
    Presse Med; 1987 Dec; 16(44):2221-5. PubMed ID: 2963317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE-I and ARBs in early diabetic nephropathy.
    Mauer M; Zinman B; Gardiner R; Drummond KN; Suissa S; Donnelly SM; Strand TD; Kramer MS; Klein R; Sinaiko AR
    J Renin Angiotensin Aldosterone Syst; 2002 Dec; 3(4):262-9. PubMed ID: 12584670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic nephropathy--the family physician's role.
    Roett MA; Liegl S; Jabbarpour Y
    Am Fam Physician; 2012 May; 85(9):883-9. PubMed ID: 22612183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors and renal failure in diabetes.
    Hiremath S; Zimmerman D; Knoll GA
    Kidney Int; 2006 Oct; 70(7):1377; author reply 1378. PubMed ID: 16988744
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of loss of renal function over time in patients with diabetic nephropathy.
    Barnett A
    Am J Med; 2006 May; 119(5 Suppl 1):S40-7. PubMed ID: 16563947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy.
    Hollenberg NK; Raij L
    Arch Intern Med; 1993 Nov; 153(21):2426-35. PubMed ID: 8215747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The ACE inhibitor spirapril in chronic renal failure, hypertension and diabetic nephropathy].
    Elliot HL
    Ter Arkh; 2000; 72(10):78-82. PubMed ID: 11220886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetes and Nephropathy: ACE inhibitor for type 1, AT1 blocker for type 2].
    Zidek W
    MMW Fortschr Med; 2004 Oct; 146(42):51-2. PubMed ID: 15536706
    [No Abstract]   [Full Text] [Related]  

  • 20. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
    Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.